Coppersmith Capital Management (5.8% stake) wants Alere (ALR -0.9%) to consider selling its drug...

|About: Alere Inc. (ALR)|By:, SA News Editor

Coppersmith Capital Management (5.8% stake) wants Alere (ALR -0.9%) to consider selling its drug testing business for ~$2.5B in order to pay down debt, according to Reuters, citing people familiar with the matter. This wouldn't be Coppersmith's first call for asset sales: the investment firm has said publicly that ALR should either sell or shutter its health management business.